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ABSTRACT 
 
The most usual type of female urinary incontinence (UI) is stress urinary incontinence (SUI). 
Conservative treatment options are helpful in mild cases, but treatment of moderate to severe SUI 
symptoms often requires operative means. Traditional operation alternatives, including open 
colposuspension and suprapubic slings, are invasive procedures associated with high risks and 
complications, whereas long-term results of less invasive operations, like needle suspension 
procedures, have been poor. Development of the tension-free vaginal tape (TVT) procedure evolved 
from the need to find an effective minimally invasive anti-incontinence procedure that could be 
performed on a day care basis under local anesthesia. 
 
This study was undertaken to investigate the short- and long-term effectiveness as well as the 
intraoperative, immediate postoperative and long-term adverse events associated with the novel 
TVT procedure and to evaluate its applicability in general clinical practice.  
 
We prospectively studied the effects and effectiveness of the TVT procedure in single center 
populations and in a multicenter population. The single center material included a heterogeneous 
group of 161 women comprising primary, recurrent, mixed urinary incontinence (MUI) and low-
pressure urethra (LPU) cases and a homogeneous group of 54 women with recurrent SUI who were 
to undergo the TVT procedure. The multicenter material included a homogeneous group of 90 
women with primary SUI who were to undergo the TVT procedure. Moreover, we retrospectively 
evaluated nationwide complications among 1455 women treated with TVT. All the involved 
surgeons were certified to perform the TVT procedure. 
 
In the short term (< 5 years) the cure rate in the heterogeneous group was 87.0% and the cure rates 
in different incontinence categories were as follows: primary SUI 88.0%, recurrent SUI 84.4%, 
MUI 81.4% and LPU 66.7%. In the homogeneous group of recurrent SUI patients, the objective 
cure rate was 89.6% and the subjective rate 80.4%. The urge symptom improvement rate was 80% 
in the heterogeneous group and in the homogeneous group the urge symptom cure rate was 100%. 
  
In the long term (≥ 5 years) the cure rate in the homogeneous group of primary SUI patients was 
84.7%. In the heterogeneous group the rate of negative postoperative cough tests was 76.7% and it 
varied from 63.6% to 79.2% in different incontinence categories, whereas the rate of negative 
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postoperative pad tests was 85.3% and it varied from 81.8% to 93.9% in different incontinence 
categories. The urge symptom cure rate ranged from 56% to 89%. 
 
Intraoperative and immediate postoperative (≤ 2 months) adverse events were recorded as follows: 
estimated bleeding of > 200 ml 0%–3.3%, bladder perforations 1.1%–5.9%, voiding difficulty 
4.3%–7.6%, retropubic hematomas 0%–3.3%, urinary tract infection (UTI) 4.1%–7.8%  and wound 
infections 0%–2.5%. In the nationwide material bladder perforation (3.8%) was the most common 
perioperative complication, whereas voiding difficulty (7.6%) was the most common postoperative 
complication. 
 
Long-term (> 2 months) adverse events were recorded as follows: de novo urge 3.1%–5.9%, 
urogenital prolapses 1.6%–2.3%, recurrent UTI 1.2%–9.3%, lower urinary tract (LUT) symptoms 
19.4% and tape exposure 3.1%.  
 
Our results suggest that after a proper training period the TVT procedure is a safe and effective anti-
incontinence operation, which can be successfully performed in the majority of patients generally 
thought to benefit from anti-incontinence surgery.  
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INTRODUCTION 
 
 
Female urinary incontinence (UI) is a common problem and its prevalence increases with age 
(Minassian et al. 2003). The most usual type of UI is stress urinary incontinence (SUI) (Minassian 
et al. 2003). Conservative treatment options, including pelvic floor exercise, physiotherapy, lifestyle 
changes and medication, can be helpful in mild cases, but the treatment of moderate to severe SUI 
symptoms, however, often requires operative means. Traditional operation alternatives, including 
open colposuspension and suprapubic slings, are very invasive procedures associated with many 
complications (Nygaard and Kreder 1994), whereas the long-term results of less invasive 
operations, like needle suspension procedures, have been poor (Bodell and Leach 2002). 
Development of the tension-free vaginal tape (TVT) procedure evolved from the great need to find 
an effective minimally invasive anti-incontinence procedure that could be performed on a day care 
basis under local anesthesia (Ulmsten et al. 1996). The applicability of this new method, however, 
needed to be examined. Therefore, we studied, mainly prospectively, the short- and long-term 
effects and effectiveness of this novel procedure. 
 
  11
REVIEW OF THE LITERATURE 
 
 
1. Urinary incontinence 
 
1.1 Definitions of urinary incontinence 
 
Urinary incontinence is the complaint of any involuntary leakage of urine, according to the 
International Continence Society. The three most commonly distinguished urinary incontinence 
types are stress urinary incontinence (SUI, the complaint of involuntary leakage on effort or 
exertion, or on sneezing or coughing), urge urinary incontinence (the complaint of involuntary 
leakage accompanied by or immediately preceded by urgency) and mixed urinary incontinence 
(MUI, the complaint of involuntary leakage associated with urgency and also with exertion, effort, 
sneezing or coughing) (Abrams et al. 2002). 
 
1.1.1 Additional terminology  
 
Intrinsic urethral sphincteric deficiency (ISD) 
McGuire observed that patients with prior failed incontinence surgery often had a low maximal 
urethral closure pressure (MUCP) of 20 cm H2O or less and presumed that these patients presented 
a special subset of SUI cases (McGuire 1981), later labeled ISD. According to the Urodynamic 
Society, ISD signifies an “intrinsic malfunction of the urethral sphincter itself” (Blaivas et al. 
1997). It has been described as a “condition in which the urethral sphincter is unable to coapt and 
generate enough resistance to retain urine in the bladder” (Lose and Brostrøm 2002; Betson et al. 
2003). Etiological factors in women include previous pelvic surgery, hypoestrogenism, aging and 
pelvic radiation (Betson et al. 2003).  
 
Low-pressure urethra (LPU) 
In addition to a rigid urethra, as in ISD, urethral pressure can also be low in cases with hyperlaxity 
of the urethral closure apparatus (Lose and Brostrøm 2002). LPU is a general term that covers both 
of these conditions and it has also been defined by MUCP cut-off values other than 20 cm H2O 
(Barranger et al. 2000). LPU has been associated with poor outcome of conventional bladder neck 
suspensions (Sand et al. 1987; Koonings et al. 1990;) and suburethral sling procedures have been 
recommended instead (Blaivas and Olsson 1988). However, the findings of some more recent 
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prospective comparative studies do not support this recommendation (Maher et al. 1999; Sand et al. 
2000). Owing to problems emerging from the significant test-retest variability of urethral pressure 
measurements (Lose et al. 1998) and the arbitrary cut-off  value of LPU, as well as the inability of 
MUCP to categorize urethral pathophysiology, the definition of LPU is unclear (Lose et al. 2002). 
 
1.2 Prevalence of female urinary incontinence 
 
Data on UI prevalence rates is affected by study material and methods as well as by the way UI is 
defined (Minassian et al. 2003). Urine loss at some time has been reported by 13–58% of women 
(Burgio et al. 1991; Brieger et al. 1997; Hannestad et al. 2002), while involuntary loss of urine that 
is a social or hygienic problem has been reported by 16–17% (Mäkinen et al. 1992; Milsom et al. 
1993). Minassian and co-workers found in their study that the commonest type of UI was stress 
(50%), then mixed (32%) and finally urge (14%) (Minassian et al. 2003). The prevalence of UI 
increases with age. Simeonova and co-workers found that 3% of women aged 20–29 years and 32% 
of women aged 80 years or more suffer from UI. They further reported that SUI was most usual 
among women aged 30–39 years, whereas in older age groups the incidence of SUI decreased as the 
incidences of urge UI and MUI increased (Simeonova et al. 1999).  Despite the fact that UI is a 
common symptom, only a relatively small proportion of women (6–26%) seek treatment (Burgio et 
al. 1991; Mäkinen et al. 1992; Simeonova et al. 1999; Hannestad et al. 2002), indicating that it is a 
concealed problem. Of women aged 30–49 years who had sought treatment for their UI, roughly 
one fourth had received operative therapy (Simeonova et al. 1999). 
 
1.3 Effect on quality of life 
 
Health-related quality of life (HRQOL) is a complex entity referring to a person’s perceptions of the 
effect of a disease and its treatment. Primary domains of HRQOL include physical, psychological 
and social functioning and perceptions of health status. Secondary domains include somatic 
sensations (symptoms), sleep disturbance, intimacy and sexual functioning, and personal 
productivity (Lose et al. 1998). Even though UI is not a life-threatening condition it has a far-
reaching impact on mental well-being (Norton 1982; Wyman et al. 1987; Stach-Lempinen et al. 
2003), relationships with family and friends, as well as on activities of daily living, and hobbies 
(Norton 1982; Wyman et al. 1987). From this it follows that health care providers should be able to 
offer effective anti-incontinence treatments that are well tolerated. Urge UI and MUI have been 
found to have an even more negative impact on quality of life than SUI (Simeonova et al. 1999).  
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1.4 Continence mechanisms 
 
According to a review article (Wall 2003), a type of incontinence where urine escapes in connection 
with exertion was described as early as 1814. Decreased tone of the bladder neck and the meatus 
urinarius in association with aging was presented as one reason for the symptom (Wall 2003). 
Subsequently, a decrease in the number of sphincteric muscle fibers (Cumston 1904) and torn or 
relaxed tissues at the bladder neck (Kelly 1913) were suggested as other reasons. It is now evident 
that the bladder neck lacks a local circular sphincter structure (Griffiths 1891; Griffiths 1895; 
Krantz 1951; Tanagho and Smith 1966). Factors that have been thought to contribute to 
incontinence include a changed urethrovesical relationship (Jeffcoate and Roberts 1952; 
Hodgkinson 1953), displacement of a smooth muscle “base plate” (Hutch 1967) and altered urethral 
length (Lapides et al. 1960; Bruschini et al. 1977).  
 
The presumption that the urogenital diaphragm divides the urethra into intra- and extrapelvic 
portions laid the basis for Enhörning’s pressure transmission theory, in which he concluded that 
passive transmission of intra-abdominal pressure to the proximal, intrapelvic, urethra was a central 
continence mechanism during exertion. He considered that the urethral portion closest to the 
bladder was of greatest significance, but he also considered the role of voluntary muscles with 
sphincteric action of importance in maintaining continence during stress (Enhörning 1961). With 
twin microtip transducer catheters it was demonstrated that intra-abdominal pressure transmission 
during stress may exceed 100% (Hilton and Stanton 1983). This, together with the finding that the 
intraurethral pressure increase preceded the abdominal one by a quarter of a second (Constantinou 
and Govan 1982) indicated the existence of an active closure mechanism which was mainly thought 
to be caused by mechanical factors (Hilton and Stanton 1983) rather than by enhanced pelvic floor 
reflex or improved muscle contraction (Heidler et al. 1979). It was further demonstrated that the 
urethral axis did not differ in continent and incontinent subjects, in a study involving use of a 
specially designed protractor (Fantl et al. 1986). 
 
Combined urethrocystometry and urethrocystography studies revealed a urethral knee formation at 
the mid-urethra, distal to the area of maximal urethral pressure (Rud et al. 1979; Westby et al. 
1982). The knee was thought to represent the site where the urethra enters the urogenital diaphragm 
(Westby et al. 1982; Huisman 1983), also known as the perineal membrane, and  maximal urethral 
pressure was found to be located approximately 0.5 cm proximally to this point (Westby et al. 
1982). It was apparent that several anatomical and physiological factors, of which some acted in the 
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urethra itself, intrinsically, and some through the periurethral supporting structures, extrinsically, 
were involved in the continence mechanism (Kessler and Constantinou 1986). 
 
1.4.1 Periurethral supporting structures 
 
The urethral portion above the urogenital diaphragm is mobile, whereas the portion below, 
approximately 20–60% of the total urethral length (DeLancey 1986), is firmly attached to the 
urogenital diaphragm (DeLancey 1990). The levator ani musculature, comprising the 
pubococcygeus, iliococcygeus and puborectalis muscles (Zacharin 1963), compose the muscles of 
the urogenital diaphragm (DeLancey 1988). The levator ani muscle is composed of a mixture of 
slow and fast twitch muscle fibers. The proportion of slow twitch fibers dominates and therefore it 
is functionally of slow twitch type. Additionally, however, it is also capable of producing rapid 
muscle contractions. The levator ani muscle exhibits features of a typical voluntary muscle and is 
suggested to play an active role in urethral closure, especially during sudden intravesical pressure 
rise (Gosling et al. 1981). Other structures involved in urethral support are the arcus tendineus 
fasciae pelvis and the endopelvic fascia, which hold the urethra and the anterior vaginal wall in 
close relationship with each other (DeLancey 1990; DeLancey 1994). Additionally, the role of 
pubourethral ligaments as a fulcrum that mediates forces directed to close the urethra have been 
emphasized (Krantz 1951). Zacharin further described this complex of ligaments, that consists of 
anterior, posterior and intermediate pubourethral ligaments, and termed it the urethral suspensory 
mechanism (Zacharin 1963). The elongated S-shape of the urethra and the close relationship of the 
proximal bend to the posterior pubic surface is proposed to be associated with this mechanism 
(Zacharin 1963), which covers the distal two-thirds of the urethra (Zacharin 1968). The posterior 
attachment sites of the ligamentous complex are of main importance for the suspensory mechanism 
(Zacharin 1968). The pubourethral ligaments are continuous with the perineal membrane (Milley 
and Nichols 1971). 
 
The so-called integral theory states that stress as well as urge symptoms arise from the same 
anatomic defect, a lax vagina. The theory proposes that the vagina functions both as a mediator of 
muscle contractions involved in the urethral closure mechanism and that it also prevents urgency by 
supporting the hypothesized stretch receptors at the proximal urethra and trigone. Muscle 
dysfunction is held responsible for nearly all instances of urinary incontinence. The defect may 
exist in the muscle itself or in the perimuscular structures that attach the muscles to the vagina. The 
most important defect is a pubourethral ligament defect (Petros and Ulmsten 1990a).  
  15
1.4.2 Intrinsic continence mechanism 
 
The striated muscle components of the urethral wall are situated along approximately 20–80% of 
the total urethral length (DeLancey 1986). They are composed of slow twitch fibers capable of 
producing a constant tone and they lack features of a typical voluntary muscle, indicating that the 
tonus might entirely be neurologically controlled (Gosling et al. 1981). There is evidence that the 
striated muscle fibers of the urethral wall extend at some points within the perineal membrane 
(Oelrich 1983). Smooth muscle is present in the proximal four-fifths of the urethra (DeLancey 
1990). A multitude of venous sinuses exceeding the requirements for ordinary tissue vascularization 
have been found submucosally in female cadaveric specimens (Berkow 1953). Vascular pulsations 
have been noticed at the urethral high pressure zone (Asmussen and Ulmsten 1983), whereas in 
histological studies submucosal vascularity has been found to be especially concentrated at the 
internal and external urethral orifice (Huisman 1983). Altogether, the role of a vascular sealing 
component in the production of intraurethral pressure has been recognized. Additionally, the 
connective tissue (DeLancey 1990) and probably also the mechanical properties of the intraluminal 
urethral wall play a role in the intrinsic continence mechanism (Zinner et al. 1980). Incontinent 
women exhibit connective tissue deterioration (Ulmsten et al. 1987; Falconer et al. 1994). 
 
Mechanisms within the bladder neck which may be involved in the closure of this region are the 
detrusor loop and the trigonal ring (Huisman 1983). 
 
Many factors that contribute to the maintenance of continence are still unclear, but it is agreed that 
an efficient urinary continence mechanism relies on an intrinsically intact urethra as well as on 
proper anatomical urethral support. Results after female orthotopic bladder replacement, where the 
bladder neck was sacrificed, have shown the important role of the mid-urethra in preserving 
continence (Stein et al. 1994; Hautmann et al. 1996). Knee formation at the mid- urethra, and 
MUCP located approximately 0.5 cm proximally from this point, as well as the fact that vascular 
pulsations have been noticed at the urethral high pressure zone, highlight further the important role 
of the mid-urethra in preserving continence.  
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2. Surgical treatment of stress urinary incontinence 
 
2.1. History of anti-incontinence surgery 
  
2.1.1 Vaginal repairs 
 
The history of anterior colporraphy begins in the 1880s, when several methods arose that employed 
the idea of narrowing the lumen of the urethra and vesical neck by dissection of the anterior vaginal 
wall and by suture placement into the suburethral tissue (Schultze 1888). The oldest anti-
incontinence procedure, still utilized to some extent in modern medicine, is anterior colporraphy 
with Kelly–Kennedy plication. In 1913 Kelly introduced an operation that he had already 
successfully practiced for more than 10 years, which aimed to correct the torn and relaxed tissue at 
the bladder neck (Kelly 1913). He sutured together the damaged tissue with two or three mattress 
sutures after revealing the bladder neck through a sagittal medial line anterior vaginal wall incision, 
finished by resecting the redundant vaginal walls and closing the wound. In 1937 Kennedy further 
refined Kelly’s plication by placing several approximating mattress sutures into the intact tissue 
beneath the bladder neck and urethra, after which he retracted the separated levator fibers with 
temporary silver wire sutures (Kennedy 1937). 
 
Ingelman-Sundberg introduced his modification in 1947, in which he created extra support under 
the plastic repair by suturing together the pubocervical ligaments and anterior portions of the 
divided bulbocavernosus and levator muscles in the midline beneath the bladder and the urethra, 
whereas the posterior portions of the levator muscles he sewed together in front of the rectum 
(Ingelman-Sundberg 1947). Incidentally he found that the divided pubocoggygeus muscles 
preserved their ability to contract and later on he named the procedure the pubococcygeus muscle 
transplant (Ingelman-Sundberg 1982). 
 
2.1.2 Suburethral slings 
 
At the beginning of the 20th century ideas of substituting the damaged or destroyed urethral 
sphincter mechanism with a muscle transplant arose. The contractility of the transplant was thought 
to be retained by preserving the blood and nerve supply of the transplant.  
 
  17
In 1907 Giordano introduced the first suburethral sling (Giordano 1907). He dissected a gracilis 
muscle flap from the inner surface of the thigh and transplanted and sutured it around the urethra. In 
1910 Goebell freed the pyramidalis muscles, except at the pubic crest, transplanted the freed ends 
and sutured them together beneath the urethrovesical junction (Goebell 1910). In 1914 Frangenheim 
modified Goebell’s technique by leaving the pyramidalis muscles attached to strips of anterior 
rectus muscle fascia, making it possible to treat even patients with poorly developed pyramidalis 
muscles (Frangenheim 1914). In 1917 Stoeckel further refined the Goebell–Frangenheim procedure 
by additional plication of the periurethral fascia, followed by fixation of the sling body beneath the 
urethra with sutures (Stoeckel 1917). 
  
Several modifications followed and other muscles were also used. However, complications were 
still common and it was also realized that the mode of action of the suburethral sling depended most 
likely on elevation of the urethrovesical junction rather than on the formation of a neosphincter. 
Fascia (both pedicled and free flaps), ligaments, dura and tendon structures now replaced muscle as 
sling material.  
 
In 1933 Price used a strip of fascia lata, which he passed first beneath the urethra, then placed it 
retropubically and finally attached the free ends to the recti muscles (Price 1933). This principle 
was also employed by Aldridge, who in 1942 described his own variation: first anterior colporraphy 
was performed and thereafter aponeurotic fascial strips from the oblique abdominal muscles were 
passed through the recti muscles and drawn suburethrally where they were united in the midline 
(Aldridge 1942). In 1978 McGuire and Lytton described a sling procedure using rectus fascia 
supported by sutures extending through the space of Retzius and attached to the rectus fascia 
(McGuire and Lytton 1978). The two last mentioned autologous fascia sling procedures then 
became the prototypes of sling operations. 
 
2.1.3 Retropubic open suspension procedures 
 
In 1946, Marshall, Pollack and Miller reported their observations in male patients with urinary 
dysfunction after excision of the rectum (Marshall et al. 1946). Mobility and marked sagging of the 
vesical base and outlet in most of the patients suggested that lack of elevation and fixation might 
cause the problem. In some cases perineal support on voiding improved the flow. After an 
experimental suprapubic suspension of the vesical outlet by suturing it to the pubis was carried out 
successfully in a male patient, a procedure for female incontinence was developed by analogy. The 
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original urethrovesical suspension procedure was described in 1949 by Marshall, Marchetti and 
Krantz and it involved a suprapubic incision exposing the space of Retzius and elevation and 
immobilization of the vesical neck and urethra by suturing them to the pubis (periosteum or 
cartilage) and the rectus muscles (Marshall et al. 1949). Occasionally the pubic sutures pulled 
through, inspiring Burch to invent his colposuspension procedure, which he described in 1961 
(Burch 1961). The principles were the same as in the procedure described by Marshall et al., but the 
sutures were placed in the perivaginal fascia and attached to Cooper’s ligament. In 1991 Vancaillie 
and Schuessler introduced a laparoscopic colposuspension technique (Vancaillie and Schuessler 
1991). 
 
2.1.4 Retropubic needle suspensions 
 
In 1959 Pereyra described his simplified suspension procedure, which did not require retropubic 
dissection (Pereyra 1959). He had developed a special needle carrier that he introduced through a 
small abdominal suprapubic stab wound via the space of Retzius and para-urethral tissues into the 
vagina. Thereafter he threaded the needle with stainless steel wire and brought both wire ends 
through the suprapubic abdominal opening by retracting the needle carrier, repeating the procedure 
contralaterally and finally elevating the urethra and bladder by lifting and tying all four wire ends 
across the midline over the rectus fascia. In time the wires would cut through the tissues and fibrous 
tissue proliferation would stabilize the urethra.  
 
Stamey developed his own needle system and suspension method, which he introduced in 1973 
(Stamey 1973). It involved vaginal exposure of the bladder trigone, Stamey needle guidance 
through two separate suprapubic incisions alongside the internal vesical neck, intraoperative 
cystoscopy to ensure correct positioning of the needle, placement of monofilament heavy nylon 
loops with vaginal Dacron® buttresses to prevent tearing of the pubocervical fascia bilaterally to the 
urethra and internal vesical neck, and tying the two suspending nylon sutures individually on top of 
the anterior rectus fascia.  
 
Pereyra collaborated with Lebherz and in 1978 they published a description of the revised Pereyra 
procedure known today as the modified Pereyra procedure (Pereyra and Lebherz 1978). The main 
innovations of the modified procedure were dissection of the anterior vaginal wall and preparation 
of the paraurethral tissues, bilateral vaginal blunt digital dissection of the retropubic space and 
helical Prolene® suture placement into the pubourethral ligaments and musculofascial tissues. 
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In 1981 Raz described his endoscopic modification, which differed from Stamey′s respective 
procedure mainly in the following steps: the retropubic space was entered from the vagina by means 
of sharp and blunt dissection, helical polypropylene or nylon sutures were used to anchor the 
vaginal wall and the deep endopelvic fascia, the needle was introduced from one abdominal 
suprapubic incision to the vaginal area and withdrawn under cystoscopic control, after which the 
suprapubic sutures were tied together (Raz 1981). 
 
In 1987 Gittes and Loughlin described a modified, simplified needle suspension procedure without 
any incisions and using monofilament mattress sutures. The procedure could be performed as 
outpatient surgery and allowed the use of local anesthesia in selected patients (Gittes and Loughlin 
1987). 
 
It was common to all early needle suspension procedures that they involved use of the abdominal 
wall as a fixation point for the suspension sutures. This in turn could cause pain and a pulling 
sensation and sometimes the sutures cut through the tissues when the muscles contracted.  
 
2.2 Modern minimally invasive continence operations 
 
2.2.1 Periurethral bulking agents 
 
The idea of periurethral injectable bulking agents is to reduce the caliber of the urethral lumen and 
to increase the resistance to urine flow. Notes on utilization of paraffin can be found from the 
beginning of the 20th century. In 1938 sclerosing agents that caused fibrosis of the periurethral 
tissues were employed (Murless 1938). Thereafter, several different compounds such as silicone, 
polytetrafluoroethylene (Teflon®), bovine collagen and autologous fat have been utilized. An 
optimal, safe and efficient agent, however, remains undiscovered and currently carbon beads 
(Durasphere®), calcium hydroxylapatite (Coaptite®) and detranomer/hyaluronic acid copolymer 
(Zuidex®/Deflux®) are being extensively studied (van Kerrebroeck et al. 2003). At present 
injections can be administered under endoscopic control by the periurethral route and also by the 
transurethral route. Insertion devices allowing transurethral injection without visualization of the 
injection site are also available (Bent 2004). 
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2.2.2 Bone anchoring procedures  
 
In 1988 Leach reported a bone fixation technique for transvaginal needle suspension (Leach 1988). 
The procedure included vaginal wall incision, dissection beneath the vaginal epithelium laterally to 
the pubic bone, perforation of the deep endopelvic fascia, mobilization of the retropubic space, 
helical placement of polypropylene suspension sutures, incorporating the full thickness of the 
anterior vaginal wall (excluding the vaginal epithelium and deep endopelvic fascia), exposure of the 
pubic tubercle through one suprapubic incision, suspension suture placement deeply into the bone 
and individual tying of each suspension suture, with the pubic tubercle as the fixation point. 
 
During the 1990s several commercial kits, Vesica® (Appell et al. 1996), Mitek® (Kane et al. 1999), 
InTac® (Madjar et al. 1998) and InFast® (Madjar et al. 2000), that employ bone anchoring devices 
for fixing a suture or sling to the posterior plane of the pubic bone (transvaginal approach) or 
superior aspect of the pubic bone (percutaneous suprapubic approach) were launched.  
 
2.2.3 Mid-urethral tape procedures 
 
2.2.3.1 Evolution from intravaginal slingplasty (IVS) to tension free vaginal tape (TVT)                       
 
The tuck procedure, one of the first procedures designed on the basis of the integral theory (Petros 
and Ulmsten 1990c),  involved excision of bilateral, approximately 0.5 cm-wide, leaf-shaped pieces 
of vaginal mucosa (extending near, but not beyond, the bladder neck) and approximation of the cut 
edges using Dexon® sutures. The aim was to restore the closure mechanism by tightening the 
vaginal hammock. The success rate at 12 months was 47% (Petros and Ulmsten 1990c).  
 
There was an interest to find a method by which damaged posterior pubourethral ligaments could be 
recreated. Therefore, a trial on dogs aimed at creating an autogenic neo-ligament was undertaken 
(Petros et al. 1990). After designing a specific tunneler that ensured minimal invasiveness and 
correct tape positioning, the investigators implanted a 5-mm Mersilene® tape retropubically as an 
inverted U on the rectus sheet, leaving the free ends in the vagina without fixation. The tapes were 
removed 8–19 weeks later. Four weeks after tape removal a fibrous tissue band in a position 
corresponding to the human posterior pubo-urethral ligament was observed. Later on this method 
was tested in humans (Petros and Ulmsten 1990b). Local anesthesia was used and a 1.5-cm incision 
was made in the mid-line just above the superior rim of the pubic bone. The bladder was drained 
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through a Foley catheter and a straight introducer was used in order to move the bladder away from 
the operating area. The tunneler was inserted immediately laterally to the urethra just behind the 
inferior surface of the pubic bone with the forefinger guiding it along the posterior surface of the 
pubic bone, whereafter it was brought out through the suprapubic skin incision. The tape was 
introduced to the needle eye, pulled down into the vagina, and the tunneler removed. After 
repeating the procedure contralaterally the vaginal ends of the tape were fixed to a silicone tube to 
allow postoperative adjustment. Bladder neck elevation was abandoned after the first six operations 
since it caused de novo urge and outflow obstruction. It was also noted in postoperative radiological 
examinations that almost all successful cases showed no bladder neck elevation. Tape removal was 
undertaken 4 to 8 weeks later as an outpatient procedure. The success rate at 12 months was 50% 
and it increased to 82% when failure cases were treated by means of an additional bilateral tuck 
operation under local anesthesia. The two-step, combined intravaginal sling and tuck operation was 
later referred to as IVS 1 (Petros and Ulmsten 1993). 
 
A later procedure, IVS 2 (Petros and Ulmsten 1993), involved tape and bilateral tuck procedures 
simultaneously and cystoscopy always prior to removal of the tunneler. The tape ends were 
trimmed and left freely protruding into the vagina. Tape removal took place 6 to 8 weeks 
postoperatively. The success rate at a mean of 15 months was 64%. Two women out of 39 
developed suprapubic abscesses after tape removal and 9 failed cases showed decreased elasticity in 
the bladder neck area due to scarring by the tuck incision. No preoperative antibiotic was used. 
 
In IVS 3 (Petros and Ulmsten 1993) two parallel columns of tapes, and antibiotic prophylaxis (i.v. 
flucloxacillin and rectal metronidazole) were used in order to prevent abscess formation. In order to 
prevent scarring, only a single midline incision, not extending beyond the bladder neck, was made 
in the vaginal mucosa. Flaps were dissected off the urethra and the edges grasped with forceps 
while the patient was coughing (with a filled bladder) until continence was achieved. The vaginal 
tape ends left were 1.5 to 2 cm long and they were fixed to the vaginal wall. No postoperative 
catheterization was routinely performed. The success rate at 12 months was 70%. Subsequent 
loosening of vaginal tension was presented as an explanation for operative failure.  
 
In IVS 4 (Petros and Ulmsten 1993) a 0.4 × 45 cm Teflon® tape was inserted as an inverted U, 
whereafter it was cut in the midline so that two parallel tape columns were created. The vaginal tape 
ends left were 1 to 2 cm long and they were fixed to the vaginal wall. “Double-breasted” vaginal 
flaps stopping approximately 1 cm below the bladder neck were created. The free ends of the flaps 
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were placed upon one another and sutured together. The primary cure rate was 72%. Failure of 
vaginal plasty was common in failure cases.  
 
In IVS 5 (Petros and Ulmsten 1993) permanent Teflon®, Mersilene® or Goretex® tapes were used. 
The tapes were inserted in a U shape at the mid-point of the urethra without tension and an 
intraoperative cough test was performed to ensure continence. After finishing the vaginal part of the 
operation, which corresponded to that of IVS 4, the urethra was pressed downwards with a hegar 
dilator to ensure that no tension was present. Cystoscopy was performed intraoperatively. The cure 
rate at 12 months was 78%. In 1995 a report involving 50 women who had been operated upon by 
means of basically the same method as described in IVS 5 and who had been followed for a mean 
of 16 months was published. Tape materials included the same as in IVS 5, and Lyodura® was also 
used. The cure rate was 78% (Ulmsten and Petros 1995). Both of the above studies involved two 
patients with a Goretex® sling and they all experienced sinus formation which necessitated tape 
removal. Failure of the vaginal plasty was common among failure cases in both studies.  
 
In 1996 an improved version of IVS was introduced in a study that involved 75 women who had 
been followed for two years. A commercial kit (Medscand AB, Johnson & Johnson, Sweden) 
comprising a 40-cm-long and 10-mm-wide Prolene® gauze sling covered by a plastic sheet, two 
disposable metal or plastic needles and a non-disposable metal handle, was used. In the last 25 
operations two 1-cm-long transverse skin incisions 6 cm apart were made instead of the single 
incision initially used. A vertical incision maximally 1.5 cm long was made in the midline of the 
suburethral vaginal wall, starting approximately 0.5 cm from the outer urethral orifice. A blunt, 
bilateral, 0.5–1.0 cm, paraurethral dissection was made through this incision with scissors. The 
plastic sheet has two uses: it prevents contamination and enables non-traumatic insertion of the 
tape. The vaginal incision was closed and vaginal skin was excised only in cases of laxity. The cure 
rate was 84%, and no sling-related problems occurred (Ulmsten et al. 1996). This operation is at 
present called the tension-free vaginal tape or TVT procedure. 
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2.2.3.2 Modifications of the TVT procedure 
 
Alternative placement methods of the mid-urethral tape comprise for the moment transobturatoric 
(Delorme 2001) and pre-pubic techniques (Daher et al. 2003). 
 
2.3 Sling materials currently employed 
 
2.3.1 Biological materials 
 
Autologous sling materials currently employed are fascia lata, rectus fascia, and vaginal wall. 
Available allogenic cadaver graft products are fascia lata and dermis. Methods that are employed to 
sterilize cadaveric tissue include solvent-dehydration, freezing, freeze-drying and γ-irradiation. 
Xenografts currently employed are porcine dermis, bovine pericardium and porcine intestinal 
mucosa (Kobashi et al. 2005). 
 
2.3.2 Synthetic materials – mesh classification  
 
Synthetic meshes are divided into absorbable and non-absorbable types (Goldstein 1999). 
Absorbable meshes (produced from polyglycolic or polylactic acid) are unsuitable for procedures 
where prolonged tensile strength is required (Tyrell et al. 1989). Non-absorbable meshes are made 
of fibers comprising one (monofilament) or several filaments (double filament/multifilament). The 
structure of the fiber can be twisted, coated (single or double wrapped), braided or double braided. 
Mesh fabrics may be woven (plain, twill or satin weave), knitted (warp-knit, interlock and circular-
knit) or nonwoven-nonknitted and the surfaces may be of the same or different materials (composite 
fabrics) (Cosson et al. 2003). Non-absorbable meshes are classified into four subtypes based on 
their pore size (Amid 1997). Type I meshes are totally macroporous (pores > 75 µ), type II meshes 
totally microporous (pores < 10 µ in at least one dimension), type III meshes macroporous with 
multifilamentous or microporous components and type IV meshes possess a submicronic structure 
(Amid 1997). The pore size of type I meshes allows admission of macrophages, fibroblasts, blood 
vessels and collagen fibers into the pores (Amid 1997), which is important in prevention of mesh-
related adverse events and for good incorporation of the host tissue throughout the mesh.  
 
Monofilamentous polypropylene mesh, which has proved to be superior to other available synthetic 
meshes, has all the qualities demanded of an ideal type I mesh: it is completely inert, infection-
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resistant, rapidly fixed and entirely incorporated. Additionally, it does not promote sinus tract 
formation and tape removal is not required in cases of non-tape-related surgical infection (Amid 
1997; Amid et al. 1995). At present polypropylene prostheses are widely used and they are 
available in various forms, including Prolene (Ethicon, Summerville, NJ, USA), Marlex (BARD, 
Cranston, RI, USA) and Atrium (Atrium, Hudson, NH, USA) (Birch and Fynes 2002). Additional 
non-absorbable materials include polytetrafluoroethylene (PTFE, Teflon), expanded PTFE (Gore-
Tex) and polyethylene terephthalate (Mersilene) (Niknejad et al. 2002). 
 
2.4 Clinical outcome of incontinence surgery 
 
Cure rates associated with pubovaginal slings vary from 46% to 95% in studies with mean or 
median follow-up periods of under 5 years (Zaragoza 1996; Chaikin et al. 1998; Choe and Staskin 
1999; Kuo 2001; Weinberger and Ostergard 1995; Young et al. 1995; Rutner et al. 2003) An 
overall success rate of 77.4% was reported in a study with a minimum follow-up period of 5 years 
(Morgan et al. 1985). These studies involved use of different sling materials as well as different 
study designs. 
 
In a non-randomized study at a mean of 4.5 years after open colposuspension, 84% of patients were 
continent but only 44% were continent and complication-free (Galloway et al. 1987). In non-
randomized studies with mean or median follow-up periods ranging from 5 to 13.8 years, cure rates 
ranged from 44% to 78% (Alcalay et al. 1995; Dietz and Wilson 2000; Drouin et al. 1999; Kinn 
1995), whereas in a study with 5 to 10 years of follow up 81.6% were cured of SUI (Feyereisl et al. 
1994). 
 
In randomized controlled trials comparing open colposuspension with laparoscopic 
colposuspension, cure rates associated with the former procedure ranged from 79% to 96% and for 
the latter procedure from 62% to 80%, the follow-up periods varying from 1 year to 2.7 years (Su et 
al. 1997; El-Toukhy and Davies 2001; Ankardal et al. 2004;).  
 
Cure rates after periurethral silicone injections have been reported to vary from 19% to 40% after 
31 to 36 months (Harriss et al. 1996; Barranger et al. 2000). Cure rates after periurethral collagen 
injections varied from 28% to 30% after 8 to 55 months (Corcos and Fournier 1999; Winters et al. 
2000). In a randomized trial no difference was found in cure rates between fat and placebo groups 
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three months after injection therapy (Lee et al. 2001). A cure rate of 31% at a mean of 78 months 
after dextranomer/hyaluronic acid copolymer injection has been reported (Stenberg et al. 2003). 
 
The cure rate after bladder neck suspension was 90% at a mean follow-up time of 15 months (Raz 
et al. 1992), being 23% at 4.4 years (Elkabir and Mee 1998) and 20% at 9.8 years (Trockman et al. 
1995).  
 
Cure rates after TVT procedures are displayed in Table 1 and cure rates after pre-pubic tape and 
transobturator tape (TOT) procedures in Table 2. 
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2.5 Complications of incontinence surgery 
 
Retropubic open suspensions and pubovaginal slings are regarded as the most effective anti-
incontinence procedures in the long term (Leach et al. 1997). However, original articles with a 
focus on the complications associated with these procedures are difficult to find. Thus, the 
complication rates presented in this section are produced from articles concentrating mainly on 
results in general. Perioperative complications associated with Burch colposuspension are presented 
in Table 3. 
 
 
Table 3. Perioperative complications associated with Burch colposuspension 
 
Stanton and 
Cardozo 1979 
Korda et al. 1989 Baker and Drutz 
1991 
Kiilholma et al. 
1993 
Kjølhede and 
Ryden 1994 
Wang 1996 
n=180 n=174 n=289 n=186 n=232 n=294 
Hemorrhage 
0.6% 
 
Bladder injury 
1.1% 
 
Abscesses 0.6% 
 
Pulmonary 
embolism 0.6% 
 
 
Ureteral injury 
1.1% 
 
Catheterization 
> 10 days 24.7% 
 
UTI 45.4% 
 
Haematoma 4.0% 
 
Wound infection 
2.9% 
 
Transfusion 1.7% 
 
Deep venous 
thrombosis 0.6% 
 
Blood 
transfusion 
33.2% 
 
Abscesses 2.4% 
 
Fever 6.2% 
 
Deep venous 
thrombosis 
1.0% 
 
Pulmonary 
embolism 0.3% 
 
 
 
Hematoma 
2.7% 
 
Voiding 
difficulty < 1 
month 14.0% 
 
UTI 14.0% 
 
Wound 
infection 4.3% 
 
Deep venous 
thrombosis 
1.1% 
 
Pulmonary 
embolism 0.5% 
 
 
 
Indwelling 
catheter > 2 
weeks 9.1% 
 
UTI 27.6% 
 
Residual urine > 
100ml > 7 d 
16.4% 
 
Fever 5.2% 
 
 
Hemorrhage 0.7% 
 
Bladder injury 
2.4% 
 
Voiding difficulty 
3 weeks after 
catheter removed 
9.5% 
 
UTI 6.8% 
 
Wound infection 
4.1% 
UTI = urinary tract infection; d = days 
 
Long-term complications after Burch colposuspension have been reported as follows: uterine/vault 
prolapse 7% (Dietz and Wilson 2000), rectocele/enterocele 30% (Feyereisl et al. 1994) to 57% 
(Dietz and Wilson 2000), cystocele 25% (Dietz and Wilson 2000), post-colposuspension syndrome 
2.3% (Feyereisl et al. 1994), persistent voiding difficulty 2 % (Dietz and Wilson 2000) to 22% 
(Alcalay et al. 1995) and urge incontinence 23% (Alcalay et al. 1995) to 41% (Dietz and Wilson 
2000). 
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Table 4 summarizes perioperative and long-term complications associated with pubovaginal slings. 
Table 5 shows respective results for the TVT procedure. 
 
2.6 Nationwide hospitalization times associated with anti-incontinence surgery according to   
      STAKES 
 
The National Research and Development Centre for Welfare and Health (STAKES) maintains a 
register of all hospital discharges in Finland. The annual numbers of patients, as well as the 
respective hospitalization times of patients who were discharged from 2000 to 2004 with an NCSP-
F (Nordic Classification of Surgical Procedures-Finland) code number referring to a tension-free 
vaginal tape procedure (LEG 10) and abdominal colposuspension (KDG 20) are summarized in 
Table 6. In the hospital discharge database, day care surgery is defined as an elective procedure 
performed under intravenous sedation or extensive regional anesthesia or general anesthesia in an 
operating theatre followed by a postoperative hospitalization period of less than 12 hours.  
Systematic problems related to the coding of the TVT procedure were usual before 2000. However, 
since 2000 the code number of the TVT procedure established its position and data can be 
considered reliable from this perspective. The number of abdominal colposuspensions has 
consistently decreased in Finland and in 2004 no procedure with the respective code number was 
reported. In contrast, TVT procedures have been extensively performed and the rate of TVT day 
care surgery has annually increased, being 54% in 2004. 
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AIMS OF THE STUDY 
 
The main goals of the present study were:  
 
1. to study the short- and long-term effectiveness of the TVT procedure 
 
2. to study the intraoperative, immediate postoperative and long-term adverse events 
associated with the TVT procedure 
 
3. to evaluate the applicability of the TVT procedure in general clinical practice 
 
 
 
SUBJECTS AND METHODS 
 
Studies I, IV and V were carried out at the urogynecological unit of Helsinki University Central 
Hospital, whereas Study II was a multicenter trial involving the above mentioned unit and two 
additional Nordic centers (Danderyds Hospital, Karolinska Institute, Stockholm and Uppsala 
University Hospital, Uppsala in Sweden). All studies were approved by the Ethics Committees in 
respective centers and informed consent was obtained from all patients involved. Study III was a 
nationwide postal questionnaire study. The set-up was prospective in Studies I, II, IV and V, and 
retrospective in Study III. 
 
 
1. Subjects (Studies I, II, IV and V) 
 
Studies I and V: Out of 332 consecutive women who were referred to the urogynecological 
outpatient clinic because of UI the studies involved all 161 who met the inclusion criteria and who 
were scheduled to have a TVT procedure. Inclusion criteria were: urodynamically proven SUI with 
observed urinary leakage during the cough stress test, no need for additional concomitant surgery, 
no existing urogenital prolapse protruding beyond the vaginal introitus and no urge-dominated 
mixed incontinence. All women had failed to respond to pelvic floor exercises. Their age varied 
from 29 to 81 years and body mass index (BMI) from 19 to 35 kg/m2. The numbers of women with 
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MUI, recurrent incontinence, and LPU were 59, 45 and 18, respectively. Recurrent SUI refers to 
patients who had undergone one or several unsuccessful anti-incontinence operations. Anterior 
repair with Kelly plication is considered as an anti-incontinence procedure, whereas anterior repair 
alone is not. No study subject had undergone previous periurethral bulking. The operations were 
performed between May 5, 1995 and March 17, 1999. 
 
Study II: Ninety consecutive women who were to undergo TVT surgery because of primary SUI 
were enrolled into the study between 1 January 1995 and 15 October 1996. All women had 
urodynamically proven SUI, 25 women had symptoms of urgency, none had LPU. A cystocele that 
maximally extended to the mid-vagina but did not require operation was acceptable. Of 90 patients 
in this study, 17 were from the Finnish center and of these 17 women 16 also participated in Studies 
I and V. 
 
Study III: In this nationwide study all women (1455) treated by means of TVT in 38 out of 40 
Finnish hospitals by the end of 1999 participated. The women had been selected to undergo TVT 
surgery according to local operation criteria in each of the 38 hospitals involved. In 40 cases 
concomitant surgery was performed. The rest of the patients underwent the TVT procedure alone. 
Patient characteristics were not reported, since the main purpose was to evaluate the problems that 
emerge when a new anti-incontinence procedure is taken into practice. 
 
Study IV: The study involved 54 successive women who were referred to the urogynecological 
outpatient clinic owing to recurrent SUI and who were scheduled to undergo a TVT procedure. The 
inclusion criteria were the same as in Study I and 45 of these patients had also participated in Study 
I. The women’s age varied from 38 to 76 years, and BMI from 20 to 30 kg/m2. 
 
The TVT operations in Studies I, II, IV and V were performed by experienced urogynecologists. 
Gynecologists of varying operative skills performed all other operations (Study III). Patient 
characteristics are displayed in Table 7.  
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Table 7. Preoperative patient characteristics  
 
 
Variable 
 
Study I 
 
Study II Study IV Study V 
 
Age (y) 
 
56 (29–81) 
 
52 (35–86) 
 
57 (38–76) 
 
55 (35–81) 
BMI (kg/m2) 
 
25 (19–35) 
 
Nr 
 
25 (20–30) 
 
25 (19–32) 
 
Parity 
Vaginal deliveries 
CS 
 
2 (0–9) 
 
 
2 (0–4) 
 
 
 
Nr 
 
 
2   (0–9) 
0   (0–3) 
Hysterectomy 
 
66  [41] 
 
Nr 
 
Nr 
 
52 [40] 
Recurrent UI  
 
45 [28] 
 
0 
 
51 [100] 
   
33 [26] 
  
Duration of symptoms (y) 
 
10 (1–50) 
 
13 (2–25) 
 
10 (1–37) 
 
10 (1–50) 
 
MUI  
 
59  [37] 
 
25 [29] 
 
3 [6] 
 
11-45 [8.5–35] 
LPU 
 
18  [11] 
 
0 
 
6 [12] 
 
11 [8.5] 
Values are given as median (range) or n [%]. 
Nr = not reported; BMI = body mass index; CS = cesarean section; UI = urinary 
incontinence; MUI = mixed urinary incontinence; LPU = low-pressure urethra 
  
 
 
2. Study protocol (Studies I, II, IV and V) 
 
Pre- and postoperative evaluation in Studies I, II, IV and V included gynecological examination, a 
cough stress test, a 24-h pad test, a voiding diary, residual urine measurement and a VAS  
estimation by the patient of the severity of urinary symptoms. Additionally, preoperative 
urodynamics were assessed in all subjects in Studies I, II, IV and V and postoperative urodynamics 
in Studies I and II, whereas 45 of 54 subjects in Study IV and 42 of 129 subjects in Study V 
underwent postoperative urodynamics. Bacteriuria was ruled out before urodynamic investigations, 
and all studies included an additional postoperative urine test. In Studies I and V the women were 
postoperatively asked to express their opinion about the operation outcome by choosing from 
various alternatives (worse, unchanged, improved and cured) the one that best suited their situation. 
Hospital records were retrospectively studied as regards previous anti-incontinence operations in 
Studies I, IV and V. 
  
Intra-operatively registered parameters were: immediate complications (Studies I–IV), the amount 
of local anesthetic (Studies I and IV), total operation time including the time for administering the 
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local anesthetic (Studies I, II and IV), any amount of blood loss (Studies I and IV) and amount of 
blood loss > 200 ml (Study II). Postoperatively, at the ward, the amount of residual urine (Studies I, 
IV) and length of hospital stay (Studies I, II, IV) were recorded. During every post-operative 
research visit hospital records were retrospectively studied as regards possible TVT-related 
problems that had emerged after hospital release (Studies I, II, IV, V).  
 
 
3. Questionnaire (Study III) 
 
A questionnaire about TVT-associated morbidity was sent to 38 out of 40 Finnish hospitals where 
TVT operations had been independently performed by the end of 1999 after an obligatory and 
systematic training period. The two excluded hospitals were the primary TVT training center and a 
hospital that did not use the standard TVT equipment. Questions covered the number of TVT 
operations performed and the numbers of the following complications: blood loss over 200 ml, 
bladder perforation, major vessel injuries, other per-operative complications, complete 
postoperative urinary retention, minor voiding difficulties (residual urine volume > 100 ml on the 
second postoperative day), retropubic hematomas, wound infection, defective healing of the vaginal 
incision, urinary tract infection, tape rejection and other postoperative complications. The nature of 
the complications was requested and the associated management procedures listed.  
 
 
4. Surgical technique (Studies I–V) 
 
The TVT procedures were performed in a standard manner as described by its inventor (Ulmsten et 
al. 1996). All surgeons were experienced urogynecologists (Studies I, II, IV and V) or 
gynecologists specially trained and certified for TVT surgery (Study III). Diluted (0.25%)  
prilocaine with adrenaline was used for local infiltration anesthesia. Diazepam, 5 mg orally, was 
given as premedication half an hour before surgery. During surgery one to three doses of 0.05 mg of 
Fentanyl® (fentanyl citrate, Janssen Pharmaceutica, Beerse, Belgium) was given intravenously for 
analgesia. One intravenous dose of 500 mg of metronidazole was given during the operation as the 
only prophylactic antibiotic treatment. The standard TVT set was used (Ethicon Inc., Sommerville, 
New Jersey, USA and Medscand Medical, Malmö, Sweden). Cystoscopy was performed twice 
during the operation, after each retropubic penetration by the TVT needle. Adjustment of the 
Prolene® tape was performed with a bladder volume of 250–400 ml. During vigorous coughing a 
  37
drop of liquid was allowed to appear at the external orifice of the urethra in order to avoid 
postoperative retention. 
 
 
5. Clinical evaluation methods 
 
5.1 Cough stress test (Studies I, II, IV, V) 
 
The cough stress test was performed with a comfortably filled bladder (bladder volume ~ 200–300 
ml), first in a semilithotomy position, and if no urine escaped, additionally in a standing position. 
Leakage in one of the positions was always registered as a positive test result. 
 
5.2 Description of urge symptoms (Studies I, II, IV, V) 
 
In Study I the subjects were considered to have urge symptoms if they answered positively to the 
question "Do you experience a strong desire to urinate in relation to stressful situations?". In Study 
II, urge symptoms included frequency, urgency and nocturia. In Study IV, women were considered 
to have urge symptoms if they had eight or more daytime micturition episodes, more than one 
nighttime micturition episode and a strong desire to urinate in relation to stressful situations. In 
Study V the definition in Study I, as well as the definition in Study IV were included and the results 
were compared.  
 
5.3 Urodynamic measurement (Studies I, II, IV, V) 
 
All urodynamic measurements were performed by gynecologists and included urethrocystometry 
and urethral profilometry in the sitting and/or semilithotomy positions according to previously 
described techniques (Ulmsten et al. 1977). The bladder was filled to ~ 300 ml with body-
temperature saline at a rate of 50 ml/min (Study II) or 70 ml/min (Studies I, IV and V). The 
following parameters were registered: first sensation, bladder capacity, urethral length, MUCP and 
detrusor contractions. LPU was defined as MUCP below 20 cm H2O at rest.  
 
  38
5.4 Visual analogue scale estimation (Studies I, II, IV, V) 
 
A 10-cm-long line was printed on paper. Zero at the left end represented no urinary problems and 
100 at the right end represented unbearable urinary problems. Patients were asked to estimate the 
severity of their SUI symptoms by ticking off the corresponding point on the line.   
 
5.5 Patients’ subjective verbal estimation (Studies I and V) 
 
The women were asked to express their subjective opinions verbally as regards the success of the 
surgery by choosing from four alternatives (worse, unchanged, improved and cured) that which best 
described their present SUI situation. 
 
5.6 Residual urine measurement (Studies I, II, IV, V) 
 
Residual urine was measured by ultrasonography (Bladderscan®) or by catheterization. 
 
5.7 Voiding diary  
 
Patients were asked to report the amount of voided urine and the time of each voiding episode 
during 24 hours (Study V) or 48 hours (Study I, II, IV).  
 
5.8 Pad tests (Studies I, II, IV, V) 
 
The women were requested to perform home pad weight tests over a 24-hour period on a day that 
resembled that of their general lifestyle, but not, however, while menstruating.  
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6. TVT training program (Study III) 
 
The university clinic in Finland that had been involved in the development of the TVT procedure 
invited one experienced urogynecologist from each of the four other university clinics to be trained 
to perform TVT operations. The indications for performing the operation and the possible risks and 
complications were carefully explained to the trainees. The importance of registering in detail 
perioperative and immediate postoperative complications was emphasized. First the trainees 
performed four to five operations together with the main instructor, after which each trainee 
performed two operations alone, with guidance from the instructor. Later on the main instructor 
visited each of the four university clinics and observed how three to four operations were carried 
out by the local TVT team. A certificate to perform TVT operations was granted if these operations 
went well. Finally, each urogynecologist in each of the four university clinics had to perform 20 
TVT operations and if the results were good after a follow-up period of six months, they were 
authorized to teach other gynecologists in smaller hospitals within their own districts. In the end, 
each central and local hospital in Finland had one certified TVT surgeon and the university clinics 
possibly had several. 
 
 
7. Reporting of operation results (Studies I, II, IV and V) 
 
Study I: Subjects were regarded as cured if they were continent during urodynamics (no leakage 
and no bladder contractions), had a negative stress test result, had leakage of < 8 g/24 h as measured 
by the pad test, scored <5 on the VAS, and if they regarded themselves as cured. Subjects were 
regarded as improved if they had a negative stress test result, an improvement of ≥ 75% on the VAS 
and if they regarded themselves as improved. The outcomes for all other patients were classified as 
failures. 
Study II: Subjects were regarded as cured if they had a negative stress test result, had leakage of     
< 10 g/24 h as measured by the pad test and if their VAS scores had improved by ≥ 90%. Subjects 
were regarded as improved if they had leakage of < 15 g/24 h or > 50% reduction of leakage as 
measured by the pad test and if their VAS scores had improved by ≥ 75%. The outcomes for all 
other patients were classified as failures. 
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Study IV: Subjects were regarded as objectively cured if they had a negative stress test result and 
leakage of < 10 g/24 h as measured by the pad test. Subjects were regarded as subjectively cured if 
they scored ≤ 10 on the VAS. Subjects were regarded as objectively improved if they had a negative 
stress test result and > 80% reduction of leakage as measured by the pad test. Subjects were 
regarded as subjectively improved if they scored ≤ 25 on the VAS. The outcomes for all other 
patients were classified as failures.  
 
Study V: The criterion for a negative pad test result was leakage of < 8 g/24 h. No other 
classifications were used. 
 
 
8. Statistical analyses 
 
In Study I binary and ordinal data from the preoperative and postoperative protocols were expressed 
as frequencies and paired t-tests were used to test changes in continuous variables. In Study II 
Wilcoxon’s rank sum test was used to test changes in continuous variables. In Study III the 
likelihood ratio test in linear models was used to determine the significance of differences between 
hospitals. In Study IV pre- and postoperative data were processed as continuous variables and 
paired t-tests were used to find differences in mean values. Because of the small patient number in 
Study IV the robustness of the t-test made its use justified, although some of the variables were not 
strictly continuous. A probability value of < 0.05 was considered statistically significant in all 
studies. In Study V pre- and postoperative urodynamic, residual urine and voiding diary data were 
compared by using paired t-tests. Data on continuous variables in Study V were compared by using 
logistic regression analyses, whereas data on binary variables were compared by using Fisher’s 
exact test. All statistical analyses were performed by using S-PLUS software (S-PLUS 2000 Guide 
to Statistics, Data Analysis Products Division, MathSoft, Seattle). 
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RESULTS 
 
1. Short-term (< 5 years) effectiveness of the TVT procedure 
 
The mean follow-up period in Study I was 1.3 years, with a range of 0.5–2 years. In Study I the cure 
rate in the total material was 87.0%, whereas the cure rates in different incontinence categories were 
as follows: primary SUI 88.0%, recurrent SUI 84.4%, MUI 81.4% and LPU 66.7%. The mean 
follow-up period in Study IV was 2.1 years, with a range of 2–5 years. Study IV involved only 
recurrent SUI patients, some of them had additional LPU or MUI; the objective cure rate was 89.6% 
and the subjective rate 80.4%.  
 
In Study I the rate of negative postoperative cough tests was 93.8% in the total material (Table 8). 
In Study IV the rate of negative postoperative cough tests varied from 66.7% to 98.0% in different 
incontinence categories (Table 8). In Study I the rate of negative postoperative pad tests was 91.1% 
in the total material and it varied from 85.0% to 100% in different incontinence categories (Table 
9). In Study IV the rate of negative postoperative pad tests varied from 66.7% to 84.3% in different 
incontinence categories (Table 9). The amount of urinary leakage measured in the pad test (Table 
10) as well as the severity scores of subjective SUI symptoms measured by means of the VAS 
(Table 11), had decreased significantly in both of the above studies after the TVT procedure. In 
Study I the urge symptom improvement rate was 80% and in Study IV the urge symptom cure rate 
was 100%. 
 
2. Long-term (≥  5 years) effectiveness of the TVT procedure  
 
The mean follow-up period in Study II was 4.7 years, with a range of 4–5.8 years. Study II involved 
only primary SUI patients, the cure rate being 84.7%, the rate of negative postoperative cough tests 
92.9% (Table 8) and the rate of negative postoperative pad tests 80% (Table 9). The mean follow-
up period in Study V was 6.0 years, with a range of 4.8–8.7 years. In Study V the rate of negative 
postoperative cough tests was 76.7% in the total material and it varied from 63.6% to 79.2% in 
different incontinence categories (Table 8). In Study V the rate of negative postoperative pad tests 
was 85.3% in the total material and it varied from 81.8% to 93.9% in different incontinence 
categories (Table 9). The amount of urinary leakage measured in the pad test (Table 10) as well as 
the severity scores of subjective SUI symptoms measured by means of the VAS (Table 11), had 
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decreased significantly in both of the above studies after the TVT procedure. In Study II the urge 
symptom cure rate was 56% and in Study V, 89%. 
 
Table 8. Rate of negative postoperative cough tests in different incontinence categories 
 
Study Follow-up Primary Recurrent MUI LPU Total 
I short term # # # # 93.8% 
IV short term - 98.0% 66.7% 83.3% 98.0% 
II long term 92.9% - # - 92.9% 
V long term 79.2% 69.7% 68.9% 63.6% 76.7% 
MUI = mixed urinary incontinence; # = data not extractable from the total results 
 
 
Table 9. Rate of negative (<10 g/24 h) postoperative pad tests in different incontinence categories 
 
Study Follow-up Primary Recurrent MUI LPU Total 
I short term 91.7% 88.9% 85.0% 100% 91.1% 
IV short term - 84.3% 66.7% 66.7% 84.3% 
II long term 80% - # - 80% 
V long term 82.3% 93.9% 82.2% 81.8% 85.3% 
MUI = mixed urinary incontinence; # = data not extractable from the total results 
 
Table 10. Pad test results 
 
Study Follow-
up  
Preoperative amount of  urinary 
leakage (g/24 h) 
Postoperative amount of urinary 
leakage (g/24 h)  
p 
I short 
term 
59 (10–365) 0 (0–33) <0.0001
IV short 
term 
62.5 (15–197) 0 (0–31) <0.0001
II long 
term 
40.5 (11–315) 0 (0–35) <0.0001
V long 
term 
57 (10–364) 0 (0–310) <0.0001
Values are median (range). 
 
 
Table 11. Visual analogue scale (VAS) results 
 
Study Follow-up Preoperative VAS score Postoperative VAS score p 
I short term 75 (25–100) 2 (0–83) <0.0001 
IV short term 80 (35–100) 3 (0–43) <0.0001 
II long term 75 (35–100) 0 (0–90) <0.0001 
V long term 75 (26–99) 4 (0–96) <0.0001  
Values are median (range). 
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3. Intraoperative and immediate postoperative (≤ 2 months) adverse events associated with 
the TVT procedure 
 
The operating time, including the time to induce local anesthesia, varied from 10 to 55 minutes 
(Studies I, II and IV). The amount of local anesthetic ranged from 60 to 98 ml (Studies I and IV). 
The mean blood loss was 16.0 ml ± 52.7 in Study I and 16.7 ml ± 49.7 in Study IV. The proportion 
of patients who were discharged in the afternoon of the operation day was 80% in Study I and 75% 
in Study IV. In Study II the hospital stay varied from 1 to 5 days, the median duration being 1 day 
at two centers and 2.5 days at the third center. There were no clinically significant differences in 
postoperative versus preoperative urodynamic parameters. The occurrence of estimated bleeding of 
> 200 ml ranged from 0% to 3.3% and the rate of bladder perforations from 1.1% to 5.9%. The rate 
of voiding difficulty varied from 4.3% to 7.6%, the rate of retropubic hematomas from 0% to 3.3%, 
the rate of UTIs from 4.1% to 7.8% and the rate of wound infections from 0% to 2.5% (Table 12). 
No clinically significant differences were noted in the postoperative versus preoperative residual 
urine volumes (Table 13). 
 
Table 12. Intraoperative and immediate postoperative adverse events associated with the TVT 
procedure  
Adverse events Study I  Study II  Study III Study IV 
Estimated bleeding > 200 ml 3/161   1.9% 3/90   3.3% 27/1455    1.9% 0/51      0% 
Bladder perforation 6/161   3.7% 1/90   1.1% 56/1455    3.8% 3/51   5.9% 
Voiding difficulty 7/161   4.3% 4/90   4.4% 111/1455  7.6% 3/51   5.9% 
Retropubic hematoma 2/161   1.2% 3/90   3.3% 27/1455    1.9% 0/51     0% 
UTI  10/161 6.2% 7/90   7.8% 59/1455    4.1% 3/51   5.9% 
Wound infection  4/161   2.5% 1/90   1.1% 12/1455    0.8% 0/51      0% 
Values are n (%).  
UTI = urinary tract infection 
 
 
Table 13. Residual urine volumes (ml) 
Study Follow-up Preoperative  Postoperative p 
I short term 5    (0–80) 0    (0–90) <0.0001
IV short term 7.5 (0–80) 10  (0–50) NS 
II long term 2    (0–75) 6.5 (0–100) 0.0002 
V long term 5    (0–80) 0    (0–302) NS 
Values are median (range). 
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In the nationwide evaluation of 1455 TVT operations, bladder perforation (3.8%) was the most 
usual perioperative complication, whereas voiding difficulty (7.6%) was the most usual 
postoperative complication (Table 14). 
 
 
 
Table 14. Nationwide number of complications associated with 1455 TVT operations performed 
in Finland by the end of 1999 
_______________________________________________________________________________ 
                                                                                                                                                 
                                                                                  n                          %                  95% CI     
 
Perioperative complications 
 Blood loss over 200 ml 27  1.9  1.2–2.7  
 Bladder perforation 56 3.8  2.9–5.0  
 Injury of the epigastric vessel 1  0.1  0.0–0.4 
 Injury of the obturator nerve 1  0.1  0.0–0.4 
 Vaginal hematoma 1  0.1  0.0–0.4 
 Urethral lesion 1  0.1  0.0–0.4 
Postoperative complications 
 Complete postoperative urinary 
retention 
34  2.3  1.6–3.3 
 Voiding difficulty 111  7.6  6.3–9.2 
 Retropubic hematoma 27  1.9  1.2–2.7 
 Hematoma outside the 
retropubic area  
7  0.5  0.2–1.0 
 Wound infection of the 
abdominal incision 
12  0.8  0.4–1.4 
 Defective healing of the vaginal 
incision 
10  0.7  0.3–1.3 
 Urinary tract infection 59  4.1  3.1–5.2  
 Urge symptoms 11  0.8  0.4–1.4  
 Dysuria 2  0.1  0.0–0.5 
 Vesicovaginal fistula 1  0.1  0.0–0.4 
 Urinary retention related to 
urological anomaly 
1  0.1  0.0–0.4 
 Pain in the region of the gluteal 
muscle and thigh 
3  0.2  0.0–0.6 
 Venous thrombosis 1  0.1  0.0–0.4 
 Seroma formation 1  0.1  0.0–0.4 
Total             367      
_______________________________________________________________________________
                                                                                                            Kuuva & Nilsson.  Acta Obstet Gynecol Scand 2002. 
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4. Long-term (> 2 months) adverse events associated with the TVT procedure 
 
In Studies I, II, IV and V the de novo urge rates varied from 3.1% to 5.9%. In Studies II and V the 
urogenital prolapse rate varied from 1.6% to 2.3% and the rate of recurrent UTI from 1.2% to 9.3%. 
In Study V LUT symptoms were reported by 19.4% of the women and the tape was visualized in 
3.1% of the women. Table 15 displays the adverse events associated with the TVT procedure at a 
mean of 6 years postoperatively.  
 
Table 15. Adverse events associated with the TVT procedure at a mean of 6 years postoperatively 
 
Urge symptoms 6/129         4.7% 
Tape visualized 4/129         3.1% 
      tape resection scheduled 2/129         1.6% 
UTI during the last 2 years                           
     1–2 infections 37/129      28.7% 
      >  2 infections 12/129        9.3% 
LUT symptoms 25/129      19.4% 
     did not feel  cessation of the  urine 
     stream 
 
2/129         1.6% 
     a stinging  feeling in the  urethra in 
     connection with  a strong desire to void  
 
1/129         0.8% 
     weaker urine  stream  11/129       8.5% 
     feeling of  incomplete  bladder  
     emptying 
 
5/129         3.9% 
     a need to urinate in a more upright 
     position  
 
4/129         3.1% 
     difficulties in  starting the urine 
     stream 
 
1/129         0.8% 
     excessive  straining in order 
     to totally empty   the bladder 
 
1/129        0.8% 
Urogenital  prolapses 2/129        1.6% 
Tape resection during the long term 
follow-up period 
 
1/129        0.8% 
Values are n (%).  
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DISCUSSION 
 
Female SUI is a major burden for the woman herself as well as for the community (Hampel et al. 
2004). The two traditional “gold standard” anti-incontinence procedures are abdominal 
colposuspensions and pubovaginal slings. However, Wiskind found in his review of 131 patients 
that 27% of the women required one or more operations to correct genital prolapse after they had 
undergone Burch colposuspension (Wiskind et al. 1992). Furthermore, morbidity associated with 
traditional slings of autologous origin is strongly related to fascial harvesting, whereas allografts 
include the potential risk of viral and prion infections (Blander and Zimmern 2000). In order to 
avoid these problems, synthetic sling materials were developed. Unfortunately, urogenital tract 
erosions, which are major complications, have been particularly associated with the non-biological 
materials (Clemens et al. 2000). Monofilament polypropylene, however, seems to be an exception, 
and at present it is regarded as the most ideal synthetic sling material (Boublil et al. 2002; Hammad 
et al. 2005). As our knowledge of continence mechanisms has increased, the role of the mid-urethra 
in maintaining continence has become evident and a notable shift in anti-incontinence operation 
practices towards mid-urethral prolene tape procedures has taken place. 
 
The present study was undertaken to study the effects and effectiveness of the new TVT procedure. 
There is no consensus of opinion concerning how cure after anti-incontinence procedures should be 
defined and what kind of outcome measures should be used (Black and Downs 1996; Hilton 2002; 
Kobashi and Govier 2005). The situation regarding the reporting of complications is the same; no 
uniform requirements exist (Black and Downs 1996). In the present study a VAS (Stach-Lempinen 
et al. 2001) was used as a quantification method for subjective SUI symptoms, whereas pad and 
stress tests were employed for objective assessment of signs of SUI. Verbal estimation as regards 
the success of the operation was included in Studies I and V. Urodynamic methods were mainly 
used to rule out preoperative detrusor overactivity. At present, however, there is evidence that TVT 
operations can be successfully performed without urodynamic evaluation (Laurikainen and 
Kiilholma 2003). Initially we included “continence during urodynamics” in the success criteria. 
Later on this criterion was abandoned owing to limited research resources and also because of the 
fact that no clinically significant changes were noted in postoperative versus preoperative 
urodynamic parameters. In the present study voiding diaries were consistently utilized to assess 
preoperative and postoperative frequencies. 
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Our initial approach in this study was to set criteria for cure as strictly as possible by combining 
results from objective as well as subjective evaluation methods. This, however, was gradually 
rejected, since it became difficult to compare the present results with other investigators’ results. In 
Study IV objective and subjective cure rates were reported separately, and in Study V the results 
were described according to the evaluation methods used. Some variation within the separate 
evaluation methods also exists in the way success was defined. In Study I, success as assessed by 
means of the VAS was defined as a VAS score of <5. This, however, turned out to be a far too rigid 
limit, since it was often difficult to interpret the exact point at which the patient had marked the 
VAS. Therefore, in Study IV success as assessed by means of the VAS was defined as a VAS score 
of ≤ 10. Leakage of <8 g/24 h was initially used as a criterion for a negative pad test result. 
However, while pad weight gains in asymptomatic women have been found to range from 0 g to   
10 g (Lose et al. 1989), pad test values of < 10 g/24 h were later on also considered to be negative 
in some of the studies.  
 
Although comparison of results from each separate study in this thesis may be difficult because of 
the above-mentioned reasons, the separate results are, however, reliable. Firstly, several widely 
accepted methods were employed for patient evaluation (Lose et al. 1998). Secondly, the clinical 
evaluation methods were carried out in a standard manner. Thirdly, the majority of the patients were 
evaluated by a clinician who did not participate in the operations. 
 
The new TVT method had only recently been launched for clinical practice when this study was 
undertaken. Only some studies of a pilot nature, comprising small case series, had previously been 
published. Although these studies were small, they were, however, very detailed, with great focus 
on the operative method as well as on the tape material. Relatively strong evidence suggested that 
this new method was feasible in clinical practice. Since the initial clinical experiences were also 
very promising, the popularity of the TVT procedure rapidly increased. The situation as a whole 
was unfavorable as regards randomization. Furthermore, knowing that patients who primarily agree 
to participate in a randomized study might withdraw when placed in a more invasive treatment 
group, we rejected the idea of randomization and chose a study set-up that would provide us with 
the second best level of evidence. 
 
In the present study the short-term cure rate after the TVT procedure was 87.0% in a heterogeneous 
patient population comprising primary SUI, recurrent SUI, MUI and LPU cases, whereas in a 
homogeneous population comprising only recurrent SUI cases the objective cure rate was 89.6% 
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and the subjective rate 80.4%. These results are in the same range as short-term results after 
pubovaginal slings (Zaragoza 1996; Chaikin et al. 1998; Choe and Staskin 1999; Kuo 2001; 
Weinberger and Ostergard 1995; Young et al. 1995; Rutner et al. 2003) and open colposuspension 
(Galloway et al. 1987). Of course a comparison like this is not watertight. However, neither Ward 
and co-workers nor Liapis and co-workers were able to demonstrate differences between cure rates 
in randomized trials when they compared the TVT procedure with abdominal colposuspension. The 
cure rate after the TVT procedure varied from 36% to 81% at six months depending on the 
assessment method (Ward et al. 2002) and it was 84% at 24 months (Liapis et al. 2002). Valpas and 
co-workers compared the TVT procedure with laparoscopic colposuspension 6 weeks 
postoperatively and demonstrated cure rates of 93% and 88% for the respective procedures (Valpas 
et al. 2003). However, at 12 months the cure rate after the TVT procedure was 86% and after 
laparoscopic colposuspension it was only 57% (Valpas et al. 2004). Like laparoscopic 
colposuspension, bladder neck needle suspensions were also formerly marketed as effective 
minimally invasive procedures. The short-term cure rate of 72% was promising, but the long-term 
rate of 43% disappointing (Bergman et al. 1989; Bergman and Elia 1995). The suggestion, that 
follow-up after surgical therapies should be ≥ 5 years is closely argued (Leach et al. 1997). 
 
In the present study, in a homogeneous population comprising only primary SUI cases the cure rate 
after the TVT procedure in the long term was 84.7%, the rate of negative cough test results 92.9% 
and the rate of negative pad test results 80%, whereas in the long term in a heterogeneous 
population comprising cases of primary SUI, recurrent SUI, MUI and LPU the rate of negative 
cough test results was 76.7% and the rate of negative pad test results was 85.3%. We found that the 
volume of urinary leakage measured in the pad test as well as the severity scores of subjective SUI 
symptoms measured by means of the VAS had decreased significantly in the long term in the 
homogeneous as well as in the heterogeneous populations. Our results are in the same range as the 
long-term results of pubovaginal slings (Morgan et al. 1985) and open colposuspension (Feyereisl 
et al. 1994; Alcalay et al. 1995; Kinn 1995; Drouin et al. 1999; Dietz and Wilson 2000; Lapitan et 
al. 2005). Unfortunately, the results of randomized controlled trials comparing the TVT procedure 
with other anti-incontinence procedures in the long term are not available. Hence level I evidence of 
the effectiveness of the TVT procedure in the long term is still lacking, although level II evidence 
exists. 
 
Complications associated with anti-incontinence surgery are common (Kinchen et al. 2004; Taub et 
al. 2005). In the present study intraoperative and immediate postoperative complications occurred at 
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low rates after the TVT procedure. We evaluated TVT operations performed at a single center and 
at three centers and registered the following complications and their incidence ranges: wound 
infection 0–2.5%, estimated bleeding > 200 ml 0–3.3%, retropubic hematoma 0–3.3%, bladder 
perforation 1.1–5.9%, voiding difficulty 4.3–5.9% and UTI 5.9–7.8%. No pneumonia or sepsis 
occurred. 
 
Regardless of a successful operation outcome when measured by objective means, a patient’s 
subjective perception can be poorer as a result of long-term adverse events. At a mean of 4.5 years 
after open colposuspension, Galloway found only 44% of the women to be both continent and 
complication-free (Galloway et al. 1987). Kobashi and Govier compared the outcome of four 
separate sling techniques (SPARC, bone anchors/polypropylene mesh, bone anchors/cadaveric 
fascia, autologous fascia) in a study that involved use of a mailed validated questionnaire at a 
minimum of six months postoperatively. Success was defined as completely dry or SUI ≤1 /week. 
Success varied from 74.9% to 85.7%, but the completely dry rate varied from 36.1% to 45.2%. 
Urinary urgency (urgency not defined in the text) with or without urge incontinence was reported at 
a rate ranging from 24.4% to 33.3% (Kobashi and Govier 2005). At a mean of 16.3 months after 
TVT surgery Manikandan and co-workers discovered (using a mailed questionnaire) that 56% of 
the patients regarded themselves as cured and 23% as improved. Urinary urgency occurred at a rate 
of 45.7%, and urgency was defined as a strong sudden desire to pass urine (Manikandan et al. 
2004). In the present study the rate of de novo urge symptoms varied from 3.1% to 5.9% and at a 
mean of 6 years after TVT surgery 68.2% of the women considered themselves to be cured. 
Generally, the TVT procedure has been associated with low de novo urge symptom rates. Segal and 
co-workers evaluated the prevalence of de novo overactive bladder symptoms from 6 weeks to 1 
year after the TVT procedure by means of a validated quality-of -life questionnaire. They found that 
4.3% of the women suffered from de novo overactive bladder symptoms, while 9.1% suffered from 
de novo urge incontinence symptoms (Segal et al. 2004). It is a general assumption that a too tightly 
placed sling might be the cause of urge symptoms. All the patients in the study reported by Segal 
and co-workers, as well as the majority of the patients in our study, underwent the TVT procedure 
under local anesthesia while all the patients in the study reported by Manikandan and co-workers 
had spinal anesthesia. It is unclear what impact this might have on the conflicting urge symptom 
rates after the TVT procedure. Additional long-term adverse events registered in the present study 
after the TVT procedure, were: urogenital prolapses 1.6–2.3%, tape exposure 3.1%, recurrent UTI 
1.2–9.3% and LUT symptoms 19.4%. We detected no cases of tape erosion. Seventeen percent of 
the women reported symptoms possibly indicating reduced flow, but the majority of these women 
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had post-void urine residual volumes ranging from 0 to 82 ml. The tape resection rate was 2.3%. No 
woman underwent tape resection due to outflow obstruction.  
 
The complication rates in the present study are similar to those reported in randomized trials in 
which the TVT procedure has been compared with abdominal colposuspension at 6 months and at 2 
years postoperatively (Ward et al. 2002; Ward et al. 2004). Moreover, Ward and Hilton 
demonstrated that TVT surgery was associated with more operative complications than 
colposuspension, but colposuspension was associated with more postoperative complications. 
Bladder injuries and vaginal perforations were particularly associated with the TVT procedure, 
whereas wound infection and fever were associated with colposuspension (Ward et al. 2002). 
 
In the present study the recorded amount of bleeding was generally low and local anesthesia was 
utilized in all cases, except in the nationwide study where additional anesthesia methods were also 
employed, because 2.7% of the women underwent concomitant surgery. However, in the 
nationwide study also, the majority of the women underwent the TVT procedure under local 
anesthesia. Operation times were short. Most of the patients were discharged from hospital later 
during the day of the operation. Some differences in hospitalization periods were noted between the 
different centers in the Nordic three-center study. In randomized studies in which the TVT 
procedure has been compared with open colposuspension, the TVT procedure has been associated 
with shorter hospitalization times and faster recovery (Liapis et al. 2002; Ward et al. 2002). The 
discharge reports provided by STAKES also show shorter hospitalization times for the TVT 
procedure than for open colposuspension, and an increasing annual amount of TVT operations are 
carried out on a day care basis. 
 
The systematic nationwide TVT training process was of a unique nature. All the trainees were 
advised to keep specific records of intraoperative as well as immediate postoperative complications. 
After exclusion of the primary TVT training center, a postal questionnaire was sent out to all 38 
Finnish hospitals where TVT operations had been independently performed (using a standard TVT 
kit) up to the end of 1999. Postoperative follow-up varied from 2 weeks to 2 months, and therefore 
it is possible that urge symptoms in this nationwide analysis were under-reported. However, the fact 
that during the training process all trainees were advised to keep specific records of complications 
adds a strong prospective element to our nationwide evaluation and the results can in most aspects 
be regarded as very reliable. All 1455 TVT operations, even the very first independently performed 
ones, were included in the study. Hence the complication rates are associated with the learning 
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curves of respective surgeons. We observed  that the complication rates clearly declined after 15 
operations. Groutz and co-workers observed in their study a decreasing bladder injury rate after 20 
operations (Groutz et al. 2002). We found no significant difference in the ratio of number of 
complications to performed TVT operations between different hospital types. In the total material of 
1455 TVT operations, injury of the epigastric vessel, injury of the obturator nerve, urethral lesion, 
vesicovaginal fistula and venous thrombosis were each reported at a rate of 0.1%. Other 
complications and their rates were found to be similar to the ones in our single center and three-
center studies. 
 
In the present study biases due to patient selection were minimized by including patient groups that 
all represented the general operation practice. The TVT operations were not only performed in 
university hospitals by extremely skilled surgeons (who had participated in elaboration of the TVT 
method), but also in other types of hospitals by ordinary gynecologists certified to carry out the 
TVT procedure. Our results suggest that after a proper training period the TVT operation is a safe 
and effective anti-incontinence procedure, which can be successfully performed in the majority of 
patients generally thought to benefit from anti-incontinence surgery.  
 
 
CONCLUSIONS 
 
On the basis of the present work, the following conclusions can be drawn: 
 
1. The TVT operation is an effective anti-incontinence procedure for treating female stress urinary 
    incontinence. 
 
2. It is a safe anti-incontinence procedure for treating female stress urinary incontinence. 
 
3. The general applicability of the TVT procedure is good. 
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